A performance evaluation of multiple classification models of human PEPT1 inhibitors and non-inhibitors

QSAR and Combinatorial Science

Volumn 26, Issue 2, 2007, Pages 220-226

  Kamphorst, Jurre ^a   Cucurull Sanchez, Lourdes ^b   Jones, Barry ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Human PEPT1 transporter; Linear discriminant analysis; Na ve Bayesian classifier; Recursive partitioning; Structure activity modelling

Indexed keywords

BARIUM COMPOUNDS; BAYESIAN NETWORKS; BIOCHEMISTRY; DISCRIMINANT ANALYSIS;

ACTIVITY MODELING; BAYESIAN CLASSIFIER; DESCRIPTORS; HUMAN PEPT1 TRANSPORTER; LINEAR DISCRIMINANT ANALYZE; NAÏVE BAYESIAN CLASSIFIER; RECURSIVE PARTITIONING; STRUCTURE - ACTIVITY MODELING; STRUCTURE ACTIVITY; STRUCTURE-ACTIVITY RELATIONSHIPS;

VIRUSES;

BETA LACTAM DERIVATIVE; PEPTIDE; PEPTIDE TRANSPORTER 1; PROTEIN INHIBITOR;

ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG STRUCTURE; DRUG TRANSPORT; HISTOGRAM; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PARTITION COEFFICIENT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

EID: 34250670713     PISSN: 1611020X     EISSN: 16110218     Source Type: Journal    
DOI: 10.1002/qsar.200630025     Document Type: Article

References (22)

1. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3-25.
2. B. S. Anand, S. Dey, A. K. Mitra, Expert Opin. Biol. 2002, 2, 607-620.
3. H. Daniel, Annu. Rev. Physiol. 2004, 66, 361-384.
4. P. V. Balimane, I. Tamai, A. Guo, T. Nakanishi, H. Kitada, F. Leibach, A. Tsuji, P. Sinko, Biochem. Biophys. Res. Commun. 1998, 250, 246-251.
5. P. W. Swaan, J. J. Tukker, J. Pharm. Sci. 1997, 86, 596-602.
6. F. Döring, J. Will, S. Amasheh, W. Clauss, H. Ahlbrecht, H. Daniel, J. Biol. Chem. 1998, 273, 23211-23218.
7. D. Meredith, C. S. Temple, N. Guha, C. J. Sword, R. Boyd, I. D. Collier, K. M. Morgan, P. D. Baily, Eur. J. Biochem. 2000, 267, 3723-3728.
8. S. Gebauer, I. Knutter, B. Hartrodt, M. Brandsch, K. Neubert, I. Thondorf, J. Med. Chem. 2003, 46, 5725-5734.
9. B. Bretschneider, M. Brandsch, R. Neubert, Pharm. Res. 1999, 16, 55-61.
10. C. U. Nielsen, B. Brodin, F. S. Jorgensen, S. Frokjaer, B. Steffansen, Expert Opin. Ther. Pat. 2002, 12, 1329-1350.
11. M. Brandsch, I. Knutter, F. Leibach, Eur. J. Pharm. Sci. 2004, 21, 53-60.
12. I. Knutter, B. Hartrodt, S. Theis, M. Foltz, M. Rastetter, H. Daniel, K. Neubert, M. Brandsch, Eur. J. Pharm. Sci. 2004, 21, 61-67.
13. I. Knutter, S. Theis, B. Hartrodt, I. Born, M. Brandsch, H. Daniel, K. Neubert, Biochemistry 2001, 40, 4454-4458.
14. M. Brandsch, I. Knutter, F. Thunecke, B. Hartrodt, I. Born, V. Borner, F. Hirche, G. Fischer, K. Neubert, Eur. J. Biochem. 1999, 266, 502-508.
15. J. Neumann, M. Bruch, S. Gebauer, M. Brandsch, Eur. J. Biochem. 2004, 271, 2012-2017.
16. V. Borner, Y. J. Fei, B. Hartrodt, V. Ganapathy, F. H. Leibach, K. Neubert, M. Brandsch, Eur. J. Biochem.1998, 255, 698-702.
17. Corina 3.10 is a program of Molecular Networks GmbH, Germany.
18. E. Migliavacca, Mini-Rev. Med. Chem. 2003, 3, 831-843.
19. Pipeline Pilot 4.5 is a program of SciTegic, USA.
20. Cerius2 4.1 is a program of Accelrys, USA.
21. C5.0 is a program of RuleQuest Research, Australia.
22. S. Wanchana, F. Yamashita, H. Hara, S. I. Fujiwara, M. Akamatsu, M. Hashida, J. Pharm. Sci. 2004, 93, 3057-3065.